BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 31888082)

  • 21. Abnormal regulation of insulin-like growth factor gene expression in peripheral blood mononuclear cells from patients with IgA nephropathy.
    Nakamura T; Ebihara I; Nagaoka I; Takahashi T; Tomino Y; Koide H
    Am J Nephrol; 1992; 12(5):292-302. PubMed ID: 1283288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of IgA receptors in the pathogenesis of IgA nephropathy.
    Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC
    J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevation of IgA in IgA nephropathy is localized in the serum and not saliva and is restricted to the IgA1 subclass.
    Layward L; Allen AC; Hattersley JM; Harper SJ; Feehally J
    Nephrol Dial Transplant; 1993; 8(1):25-8. PubMed ID: 8381930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H; Yasutake J; Makita Y; Tanbo Y; Yamasaki K; Sofue T; Kano T; Suzuki Y
    Kidney Int; 2018 Mar; 93(3):700-705. PubMed ID: 29329643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TLR9 and BAFF: their expression in patients with IgA nephropathy.
    Li W; Peng X; Liu Y; Liu H; Liu F; He L; Liu Y; Zhang F; Guo C; Chen G; Zhang L; Dong Z; Peng Y
    Mol Med Rep; 2014 Sep; 10(3):1469-74. PubMed ID: 24993857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Capsaicin induces high expression of BAFF and aberrantly glycosylated IgA1 of tonsillar mononuclear cells in IgA nephropathy patients.
    Shao J; Peng Y; He L; Liu H; Chen X; Peng X
    Hum Immunol; 2014 Oct; 75(10):1034-9. PubMed ID: 25167771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy.
    Xie YX; He LY; Chen X; Peng XF; Ye MY; Zhao YJ; Yan WZ; Liu C; Shao J; Peng YM
    Int Urol Nephrol; 2016 Nov; 48(11):1855-1861. PubMed ID: 27465795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological abnormalities in family members of patients with IgA nephropathy.
    Miyazaki M
    Jpn J Med; 1990; 29(5):469-77. PubMed ID: 1982451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine-induced immunoglobulin production in primary IgA nephropathy.
    van den Wall Bake AW; Crowley-Nowick PA; Kulhavy R; Hermans J; Jackson S; Julian BA; Mestecky J
    Am J Kidney Dis; 1992 Dec; 20(6):611-7. PubMed ID: 1462991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic characterization of cytokine expression in patients with IgA nephropathy.
    Yano N; Endoh M; Nomoto Y; Sakai H; Fadden K; Rifai A
    J Clin Immunol; 1997 Sep; 17(5):396-403. PubMed ID: 9327339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy.
    Lin X; Ding J; Zhu L; Shi S; Jiang L; Zhao M; Zhang H
    Nephrol Dial Transplant; 2009 Nov; 24(11):3372-5. PubMed ID: 19531670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated levels of IL-6 in IgA nephropathy patients are induced by an epigenetically driven mechanism modulated by viral and bacterial RNA.
    Sallustio F; Picerno A; Cimmarusti MT; Montenegro F; Curci C; De Palma G; Sivo C; Annese F; Fontò G; Stasi A; Pesce F; Tafuri S; Di Leo V; Gesualdo L
    Eur J Intern Med; 2023 Dec; 118():108-117. PubMed ID: 37550110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.
    Chen P; Shi SF; Qu Z; Zhao N; Xie XF; Lv JC; Liu LJ; Zhang H
    Ren Fail; 2018 Nov; 40(1):213-218. PubMed ID: 29619862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered production of IgE and IgA induced by IL-4 in peripheral blood mononuclear cells from patients with IgA nephropathy.
    Yano N; Endoh M; Miyazaki M; Yamauchi F; Nomoto Y; Sakai H
    Clin Exp Immunol; 1992 May; 88(2):295-300. PubMed ID: 1572094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant IgA1 Glycosylation in IgA Nephropathy: A Systematic Review.
    Sun Q; Zhang Z; Zhang H; Liu X
    PLoS One; 2016; 11(11):e0166700. PubMed ID: 27870872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased IgA1 response after primary oral immunization with live typhoid vaccine in primary IgA nephropathy.
    Roodnat JI; de Fijter JW; van Kooten C; Daha MR; van Es LA
    Nephrol Dial Transplant; 1999 Feb; 14(2):353-9. PubMed ID: 10069188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-transplant immunoglobulin A deposition and nephropathy in allografts.
    Sofue T; Suzuki H; Ueda N; Kushida Y; Minamino T
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():4-9. PubMed ID: 29968406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omics are Getting Us Closer to Understanding IgA Nephropathy.
    Mucha K; Pac M; Pączek L
    Arch Immunol Ther Exp (Warsz); 2023 Apr; 71(1):12. PubMed ID: 37060455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies of the molecular basis of IgA production, subclass regulation and class-switch recombination in IgA nephropathy patients.
    Baskin B; Pettersson E; Rekola S; Smith CI; Islam KB
    Clin Exp Immunol; 1996 Dec; 106(3):509-17. PubMed ID: 8973620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
    Novak J; Tomana M; Matousovic K; Brown R; Hall S; Novak L; Julian BA; Wyatt RJ; Mestecky J
    Kidney Int; 2005 Feb; 67(2):504-13. PubMed ID: 15673298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.